[MiR-125b-5 suppresses ovarian cancer cell migration and invasion by targeted downregulation of CD147]

Z Huang1, H Shen2, H Deng2

  • 1Department of Hematology, Hunan Provincial People's Hospital, Changsha 410005, China.

Abstract

Insights

MicroRNA-125b-5p (miR-125b-5p) inhibits ovarian cancer cell migration and invasion by downregulating CD147 expression. This finding offers a potential therapeutic target for ovarian cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Ovarian cancer is a leading cause of cancer-related death in women.
  • Dysregulation of microRNAs (miRNAs) and their target genes plays a crucial role in ovarian cancer progression.
  • CD147 is implicated in various cancers, but its role in ovarian cancer remains to be fully elucidated.

Purpose of the Study:

  • To investigate the role of miR-125b-5p in regulating ovarian cancer cell behaviors.
  • To determine if miR-125b-5p targets CD147 expression in ovarian cancer cells.
  • To explore the potential of the miR-125b-5p/CD147 axis as a therapeutic target.

Main Methods:

  • Quantitative real-time PCR (RT-qPCR) and Western blotting to assess miR-125b-5p and CD147 expression.
  • Cell proliferation, migration, and invasion assays (CCK-8, colony formation, Transwell) to evaluate cellular behaviors.
  • Bioinformatic prediction (Starbase) and dual-luciferase reporter assays to confirm the targeting relationship between miR-125b-5p and CD147.
  • Transfection experiments with miR-125b-5p mimics/inhibitors and CD147 plasmids in ovarian cancer cell lines (SKOV3, HO8910).

Main Results:

  • miR-125b-5p expression was significantly decreased, while CD147 expression was increased in ovarian cancer tissues and cell lines.
  • Overexpression of miR-125b-5p suppressed ovarian cancer cell proliferation, migration, and invasion.
  • Downregulation of miR-125b-5p promoted these cellular processes.
  • miR-125b-5p directly targets CD147, negatively regulating its expression.
  • Restoring CD147 expression attenuated the inhibitory effects of miR-125b-5p.

Conclusions:

  • miR-125b-5p acts as a tumor suppressor in ovarian cancer.
  • The miR-125b-5p/CD147 axis is a critical regulator of ovarian cancer cell migration and invasion.
  • Targeting this pathway holds promise for novel ovarian cancer therapies.